Imaging and clinical characteristics of focal atrophy of segments 2 and 3 in primary sclerosing cholangitis

被引:6
作者
Caldwell, SH
Hespenheide, EE
Harris, D
De Lange, EE
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Dept Radiol, Charlottesville, VA 22908 USA
关键词
focal atrophy; hepatic atrophy; primary sclerosing cholangitis;
D O I
10.1046/j.1440-1746.2001.02432.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Focal atrophy in primary sclerosing cholangitis (PSC) is usually thought to result from severe biliary stricture and focal biliary cirrhosis. Atrophy of the left lateral segments (segments 2 and 3) are striking when observed grossly. This type of atrophy may be subtle on cross-sectional imaging and by endoscopic retrograde cholangiopancreatography (ERCP) because of the peripheral location and compensatory hypertrophy of other parts of the liver. We examined 44 consecutive PSC patients to determine the incidence and clinical characteristics of this abnormality, and to correlate imaging studies with the gross appearance. Methods: We reviewed all cases of PSC encountered over a 3 year period ascertained from the liver disease registry. Magnetic resonance imaging or CT images were re-examined for evidence of segment 2 and 3 atrophy. Results: Four of 44 patients had focal segment 2 and 3 atrophy. These four had been confirmed laparoscopically or by inspection of the liver explant. The remaining segments of the liver were relatively spared of injury in two of the patients, and three of the four patients had preserved synthetic function without evidence of portal hypertension. While the abnormality is clearly visible on cross-sectional imaging, its peripheral location caused it to be an unobtrusive. Likewise, ERCP did not clearly reveal the abnormality on initial inspection. Conclusions: We conclude that focal atrophy of segments 2 and 3 is a sometimes early and subtle finding in PSC that may be overlooked in cross-sectional imaging or ERCP unless specifically sought. (C) 2001 Blackwell Science Asia Pty Ltd.
引用
收藏
页码:220 / 224
页数:5
相关论文
共 13 条
[1]   Intrahepatic biliary endoscopy in sclerosing cholangitis [J].
Caldwell, SH ;
Oelsner, DH ;
Bickston, SJ ;
Mays, K ;
Yeaton, P .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1996, 23 (02) :152-156
[3]   Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis [J].
Gohlke, F ;
Lohse, AW ;
Dienes, HP ;
Lohr, H ;
MarkerHermann, E ;
Gerken, G ;
zumBuschenfelde, KHM .
JOURNAL OF HEPATOLOGY, 1996, 24 (06) :699-705
[4]   PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH LIVER ATROPHY [J].
HADJIS, NS ;
ADAM, A ;
BLENKHARN, I ;
HATZIS, G ;
BENJAMIN, IS ;
BLUMGART, LH .
AMERICAN JOURNAL OF SURGERY, 1989, 158 (01) :43-47
[5]  
HALES MR, 1959, AM J PATHOL, V35, P909
[6]   IMPROVED SURVIVAL WITH PRIMARY SCLEROSING CHOLANGITIS - A REVIEW OF CLINICOPATHOLOGICAL FEATURES AND COMPARISON OF SYMPTOMATIC AND ASYMPTOMATIC PATIENTS [J].
HELZBERG, JH ;
PETERSEN, JM ;
BOYER, JL .
GASTROENTEROLOGY, 1987, 92 (06) :1869-1875
[7]   PRIMARY SCLEROSING CHOLANGITIS [J].
LEE, YM ;
KAPLAN, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :924-933
[8]  
LUDWIG J, 1989, AM J SURG PATHOL, V13, P43
[9]  
MACMAHON HE, 1955, LAB INVEST, V4, P243
[10]   Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas [J].
Miyoshi, H ;
Rust, C ;
Roberts, PJ ;
Burgart, LJ ;
Gores, GJ .
GASTROENTEROLOGY, 1999, 117 (03) :669-677